1985
DOI: 10.1016/0022-1759(85)90271-6
|View full text |Cite
|
Sign up to set email alerts
|

Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibody

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
34
0
2

Year Published

1987
1987
2007
2007

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 61 publications
(36 citation statements)
references
References 5 publications
0
34
0
2
Order By: Relevance
“…6). 7 Upper, lanes 2 and 3) relative to the colorectal carcinoma cell line SW948 (Fig. 7 Upper, lane 1).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…6). 7 Upper, lanes 2 and 3) relative to the colorectal carcinoma cell line SW948 (Fig. 7 Upper, lane 1).…”
Section: Resultsmentioning
confidence: 99%
“…When human subjects with gastrointestinal adenocarcinoma were inoculated with mAb C017-1A (Abl), many of the patients produced anti-idiotype antibody (Ab2) that reacted with the binding site of the Abl (6,7). In theory, the administration of internal image Ab2 alone may effect an antitumor response.…”
mentioning
confidence: 99%
“…Sci. USA 88 (1991) Abl-treated patients, since the Ab2 concentration can reach over 40 ,ug/ml in the blood (12,13). In several studies, it was observed that the clinical anti-tumor response in patients treated with Abl to various TAA correlated with the presence of Ab2 (25,27).…”
Section: Discussionmentioning
confidence: 99%
“…Some clinical trials have been initiated in which Ab2 were generated in animals (goat or mouse) to be administered to human cancer patients (10,11). Humans can also represent a potential source ofAb2; indeed, cancer patients receiving an anti-TAA of animal origin will usually produce antibodies to this Abl and these anti-immunoglobulin antibodies will include both antibodies to the constant regions and Ab2 (12,13). In this report, we show that Ab2,B mimicking a carcinoembryonic antigen (CEA) epitope are produced by a patient treated with NP-4, a murine monoclonal antibody to CEA.…”
mentioning
confidence: 99%
“…They are now used for in vivo diagnosis and therapy in many situations, and the development of human antibodies against both the constant and variable regions of mouse immunoglobulin has been well documented (1,2).…”
mentioning
confidence: 99%